Arya Roy

13PUBLICATIONS
43CO-AUTHORS
Medical biochemistry and metabolomics not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 25, 2025
Clinical Characteristics and Survival Trends of Male Breast Cancer in the United States: A Propensity Score Matched Analysis.

Jayasree Krishnan, Malak Alharbi, Kristopher Attwood

|Dec 17, 2024
Breast biomarkers evolution between primary and distant metastasis: incidence and significance.

Maha Khedr, Shipra Gandhi, Arya Mariam Roy

|Oct 01, 2024
Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Sabah Alaklabi, Arya Mariam Roy, Paola Zagami

|Jan 12, 2024
Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline <i>BRCA</i> mutation?

Sabah Alaklabi, Arya Mariam Roy, Lubna N Chaudhary

Pageof 3